Conley, A.P.; Wang, W.-L.; Livingston, J.A.; Ravi, V.; Tsai, J.-W.; Ali, A.; Ingram, D.R.; Lowery, C.D.; Roland, C.L.; Somaiah, N.;
et al. MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers 2019, 11, 677.
https://doi.org/10.3390/cancers11050677
AMA Style
Conley AP, Wang W-L, Livingston JA, Ravi V, Tsai J-W, Ali A, Ingram DR, Lowery CD, Roland CL, Somaiah N,
et al. MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers. 2019; 11(5):677.
https://doi.org/10.3390/cancers11050677
Chicago/Turabian Style
Conley, Anthony P., Wei-Lien Wang, John A. Livingston, Vinod Ravi, Jen-Wei Tsai, Ali Ali, Davis R. Ingram, Caitlin D. Lowery, Christina L. Roland, Neeta Somaiah,
and et al. 2019. "MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma" Cancers 11, no. 5: 677.
https://doi.org/10.3390/cancers11050677
APA Style
Conley, A. P., Wang, W. -L., Livingston, J. A., Ravi, V., Tsai, J. -W., Ali, A., Ingram, D. R., Lowery, C. D., Roland, C. L., Somaiah, N., Hwu, P., Yee, C., Subbiah, V., Futreal, A., Lazar, A. J., Patel, S., & Roszik, J.
(2019). MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers, 11(5), 677.
https://doi.org/10.3390/cancers11050677